Involvement of CD95/Apo1/Fas in Cell Death After Myocardial Ischemia
about
Small molecules, big effects: the role of microRNAs in regulation of cardiomyocyte deathHypoxia predisposes neonatal rat ventricular myocytes to apoptosis induced by activation of the Fas (CD95/Apo-1) receptor: Fas activation and apoptosis in hypoxic myocytesPotential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarctionApoptosis in ischemic heart diseaseHydrogen sulfide attenuates cardiac dysfunction in a rat model of heart failure: a mechanism through cardiac mitochondrial protectionThe role of apoptotic cell death in cardiovascular disease.Critical role of interferon regulatory factor-1 in murine liver transplant ischemia reperfusion injury.Ischemic preconditioning: fact or fantasy?Targeting ischemic cardiac dysfunction through gene transfer.Cold ischemic injury of transplanted kidneys: new insights from experimental studies.Don't lose heart--therapeutic value of apoptosis prevention in the treatment of cardiovascular disease.Mitochondrial membrane permeabilization and cell death during myocardial infarction: roles of calcium and reactive oxygen species.Simplified apoptotic cascades.Programmed cell death in cardiac myocytes: strategies to maximize post-ischemic salvage.Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heartSome lessons from the tissue transglutaminase knockout mouse.Role of apoptosis in cardiovascular disease.Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome.There is more to life than revascularization: therapeutic targeting of myocardial ischemia/reperfusion injury.Redox-mediated programed death of myocardial cells after cardiac arrest and cardiopulmonary resuscitation.TNF revisited: osteoprotegerin and TNF-related molecules in heart failure.Caspase-3 as a therapeutic target for heart failure.Mechanisms of myocardial ischemia-reperfusion injury and the cytoprotective role of minocycline: scope and limitations.Abnormalities in Alternative Splicing of Apoptotic Genes and Cardiovascular Diseases.Ischemia/Reperfusion.The tumor necrosis factor superfamily in heart failure.CD95/Apo-1/Fas: independent cell death induced by doxorubicin in normal cultured cardiomyocytes.Endothelial cell overexpression of fas ligand attenuates ischemia-reperfusion injury in the heart.Adipose-derived stem cell-released osteoprotegerin protects cardiomyocytes from reactive oxygen species-induced cell death.Inhibition of cytochrome c release by 10-N-nonyl acridine orange, a cardiolipin-specific dye, during myocardial ischemia-reperfusion in the rat.Importance of FADD signaling in serum deprivation- and hypoxia-induced cardiomyocyte apoptosis.The Fas receptor-1,4,5-IP3 cascade: a potential target for treating heart failure and arrhythmias.Retroinfusion of NFkappaB decoy oligonucleotide extends cardioprotection achieved by CD18 inhibition in a preclinical study of myocardial ischemia and retroinfusion in pigs.Balanced expression of mitochondrial apoptosis regulatory proteins correlates with long-term survival of cardiac allografts.Protein kinase Cdelta activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving BAD and the mitochondria.Fas-independent mitochondrial damage triggers cardiomyocyte death after ischemia-reperfusion.Synchronous progression of calcium transient-dependent beating and sarcomere destruction in apoptotic adult cardiomyocytes.Gene transfer of the pancaspase inhibitor P35 reduces myocardial infarct size and improves cardiac function.Prognostic value of apoptosis markers in advanced heart failure patients.Modulation of Fas-Fas Ligand Interaction Rehabilitates Hypoxia-Induced Apoptosis of Mesenchymal Stem Cells in Ischemic Myocardium Niche.
P2860
Q26995349-27D42A2E-AB6B-4BAD-941D-EEE292682860Q28564545-83F25FC6-06A7-4E17-B2AC-0762A8351267Q33409850-DF63CA41-3DB9-4179-8694-384B85DC8A2FQ33623568-EA4AA624-B665-47ED-A665-2A3884F4C0C0Q34277445-4D4F359D-D138-4CE9-9FC0-036B11655463Q34329506-76A8B237-150C-43D5-823F-E9F96CA0F253Q34401648-A75AE19F-F71E-432D-9B62-B64436EBE778Q35087829-02F57E3C-4927-4191-B3E0-80248B5392C1Q35095412-663EABBB-79FA-422E-93A7-E97DE4478377Q35844620-A8867A57-4652-4A0E-835C-239E3086F2D6Q36275682-E00EA692-DAF0-4144-B7B7-87898C2028B5Q36582810-06DAA0B9-5474-4024-A638-486D456DB9E7Q37032338-CA088BCE-6FB2-4A72-8350-8ABFF1BDC7EAQ37051197-A364B964-B87A-45F7-9360-6813674ABB45Q37088298-EF3C7554-9D56-4387-B060-E0E21B35FCAEQ37201502-88265CC3-E276-4307-9371-387703351285Q37368042-268EE837-B3A0-46CA-8D88-402788F36BD9Q37661552-0B9B65C6-0DD4-4B9B-A1F5-12CAED3531C3Q37774394-7A540985-5C5A-4E1E-BB1F-4FC96FEFB441Q37983931-1B9CA721-7322-4417-8B26-DF60AB908AC8Q37997644-89B22662-72CB-4E8F-A1CC-40F2163D0FD6Q38072123-8E38C81E-2970-4519-A933-79349A3BAD9CQ38326656-C9ECBC9B-EA6C-44D3-BF0F-50A0EBF46F94Q38637311-4133153F-2233-49AC-96DA-394E7E3859ECQ39109413-004767EC-CD59-4AB6-949E-D0044E318868Q40361542-2106B56E-E6D1-43C3-8FB7-884B3B764493Q40459939-539DDA91-7962-4ECA-883F-9A2D42CCD3A9Q40671712-CE28F0D5-251F-4AC6-BC53-08B7DAC76180Q41718620-CA99BB37-44BB-4CED-9054-471A85A89C3DQ43235366-5EA6C0E8-7656-4852-A6F6-FD5FF84BC6E2Q44026937-4555651C-6CAB-4CA9-8CFE-CE7BD4721839Q44939618-3A27FB5B-7549-4945-896A-F3AD1B064996Q45885035-BF0DC2CF-DDB7-47DA-88D0-1BB1A15DD4E2Q46149874-6A027BD7-E0ED-4550-A0CB-BF0D200107ADQ46230285-CEFDDB8F-4DB1-4222-A575-A063F3AA147BQ46592230-36EF9D7E-9E2E-4032-99D0-1E64D2DE72BDQ46801157-459C0577-2B8F-424D-BE93-025D3349DD38Q47377679-F124431F-76D9-48A6-9CB9-72BCB9E0FE9DQ48765555-55F4B945-7169-4E7D-A95A-D20F8745A1C0Q51724014-AB8F7D1D-DEDA-4F35-BD92-D13C70FD2A12
P2860
Involvement of CD95/Apo1/Fas in Cell Death After Myocardial Ischemia
description
im August 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 August 2000
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2000
@uk
name
Involvement of CD95/Apo1/Fas in Cell Death After Myocardial Ischemia
@en
Involvement of CD95/Apo1/Fas in Cell Death After Myocardial Ischemia
@nl
type
label
Involvement of CD95/Apo1/Fas in Cell Death After Myocardial Ischemia
@en
Involvement of CD95/Apo1/Fas in Cell Death After Myocardial Ischemia
@nl
prefLabel
Involvement of CD95/Apo1/Fas in Cell Death After Myocardial Ischemia
@en
Involvement of CD95/Apo1/Fas in Cell Death After Myocardial Ischemia
@nl
P2093
P50
P356
P1433
P1476
Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia
@en
P2093
Boekstegers P
Habazettl H
Schenkel J
P304
P356
10.1161/01.CIR.102.8.915
P407
P577
2000-08-01T00:00:00Z